德源药业
(920735)
| 流通市值：28.86亿 | | | 总市值：32.64亿 |
| 流通股本：1.14亿 | | | 总股本：1.29亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 597,402,013.06 | 294,181,481.42 | 1,057,759,831.41 | 795,824,946.03 |
| 营业总成本 | 439,712,417.99 | 229,701,547.23 | 800,394,506.98 | 606,640,908.29 |
| 其他经营收益 | | | | |
| 营业利润 | 161,606,184.83 | 66,046,362.96 | 268,244,588.13 | 195,940,558.26 |
| 利润总额 | 161,661,117.72 | 66,090,536.22 | 266,581,965.12 | 194,320,272.32 |
| 净利润 | 128,659,223.95 | 55,513,502.4 | 236,929,075.58 | 158,926,370.94 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 128,659,223.95 | 55,513,502.4 | 236,929,075.58 | 158,926,370.94 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 980,864,446.47 | 935,331,322.76 | 859,484,472.08 | 836,495,944.66 |
| 非流动资产: | | | | |
| 非流动资产合计 | 729,731,095.03 | 718,070,932.38 | 711,609,191.36 | 694,038,480.37 |
| 资产总计 | 1,710,595,541.5 | 1,653,402,255.14 | 1,571,093,663.44 | 1,530,534,425.03 |
| 流动负债: | | | | |
| 流动负债合计 | 244,426,006.12 | 259,278,122.43 | 192,269,197.3 | 228,701,810.83 |
| 非流动负债: | | | | |
| 非流动负债合计 | 77,545,929.43 | 78,646,248.31 | 71,933,688.14 | 72,944,540.84 |
| 负债合计 | 321,971,935.55 | 337,924,370.74 | 264,202,885.44 | 301,646,351.67 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,388,623,605.95 | 1,315,477,884.4 | 1,306,890,778 | 1,228,888,073.36 |
| 股东权益合计 | 1,388,623,605.95 | 1,315,477,884.4 | 1,306,890,778 | 1,228,888,073.36 |
| 负债和股东权益合计 | 1,710,595,541.5 | 1,653,402,255.14 | 1,571,093,663.44 | 1,530,534,425.03 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 567,934,756.5 | 285,544,901.38 | 1,098,035,941.41 | 810,185,823.46 |
| 经营活动现金流出小计 | 500,788,077.65 | 250,717,867.58 | 941,368,857.52 | 701,166,081.23 |
| 经营活动产生的现金流量净额 | 67,146,678.85 | 34,827,033.8 | 156,667,083.89 | 109,019,742.23 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 664,999,751.88 | 281,442,878.73 | 1,866,375,267.98 | 1,406,919,714.79 |
| 投资活动现金流出小计 | 664,459,779.23 | 277,823,804.85 | 2,174,345,684.51 | 1,688,569,367.81 |
| 投资活动产生的现金流量净额 | 539,972.65 | 3,619,073.88 | -307,970,416.53 | -281,649,653.02 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 4,252,388.38 | 245,000 | 8,790,000 | - |
| 筹资活动现金流出小计 | 47,664,396.2 | 646,155.08 | 64,370,318.79 | 64,360,424.63 |
| 筹资活动产生的现金流量净额 | -43,412,007.82 | -401,155.08 | -55,580,318.79 | -64,360,424.63 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | 24,274,643.68 | 38,044,952.6 | -206,883,651.43 | -236,990,335.42 |
| 期末现金及现金等价物余额 | 121,369,596.54 | 135,139,905.46 | 97,094,952.86 | 66,988,268.87 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 24,274,643.68 | - | -206,883,651.43 | - |